Antibody and Vaccine Group
Antibody and Vaccine Group

Projects

Find out what research we're carrying out now and search past projects.

B7-H3/GD2 Trispecific antibodies in Neuroblastoma

Status: Active
Lead researchers: Professor Juliet Gray

CRUK - Targeting Myeloid Cells For Improved Antibody Immunotherapy - DRCRPG-May23/100001

Status: Active
Lead researchers: Professor Mark Cragg

Developing immunostimulatory antibodies to deliver agonism without toxicity

Status: Active
Lead researchers: Professor Aymen Al-Shamkhani

In-depth T-cell analysis of individuals with haematological malignancies within STRAVINSKY (TUNE)

Status: Active
Lead researchers: Professor Sean Lim

Understanding and improving the mechanisms of action of anti-GD2 monoclonal antibody therapy in neuroblastoma

Status: Not active
Lead researchers: Professor Juliet Gray, Professor Stephen Beers